Activation of AP-1 through reactive oxygen species by angiotensin II in rat cardiomyocytes

Free Radical Biology and Medicine

Volumn 39, Issue 12, 2005, Pages 1601-1610

  Wu, Shuling ^a   Gao, Jianping ^b   Ohlemeyer, Carsten ^c   Roos, Dirk ^d   Niessen, Hans ^e   Köttgen, Eckart ^a   Geßner, Reinhard ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b KATHARINENHOSPITAL   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Angiotensin II; AP 1; Cardiomyocyte; Free radicals; NAD(P)H oxidase components; ROS

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ACETYLCYSTEINE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIOXIDANT; CANDESARTAN; DIPHENYLIODONIUM SALT; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL SIZE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; GENE EXPRESSION; HEART MUSCLE CELL; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; RAT; RAT STRAIN;

ACETYLCYSTEINE; ANGIOTENSIN II; ANIMALS; ANTIOXIDANTS; BENZIMIDAZOLES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HEART VENTRICLES; HL-60 CELLS; HUMANS; MYOCYTES, CARDIAC; NADPH OXIDASE; ONIUM COMPOUNDS; OXIDATION-REDUCTION; RATS; RATS, WISTAR; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; TETRAZOLES; TIME FACTORS; TRANSCRIPTION FACTOR AP-1;

ANIMALIA;

EID: 27844595309     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.08.006     Document Type: Article

References (50)

1. P. Lijnen, and V. Petrov Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes J. Mol. Cell. Cardiol. 31 1999 949 970
2. K.M. Baker, G.W. Booz, and D.E. Dostal Cardiac actions of angiotensin II: role of an intracardiac renin-angiotensin system Annu. Rev. Physiol. 54 1992 227 241
3. E. Giasson, and S. Meloche Role of p70 S6 protein kinase in angiotensin II-induced protein synthesis in vascular smooth muscle cells J. Biol. Chem. 270 1995 5225 5231
4. M. Ushio-Fukai, R.W. Alexander, M. Akers, Q. Yin, Y. Fujio, K. Walsh, and K.K. Griendling Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells J. Biol. Chem. 274 1999 22699 22704
5. C.D. McWhinney, R.A. Hunt, K.M. Conrad, D.E. Dostal, and K.M. Baker The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes J. Mol. Cell. Cardiol. 29 1997 2513 2524
6. K. Nakamura, K. Fushimi, H. Kouchi, K. Mihara, M. Miyazaki, T. Ohe, and M. Namba Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor-alpha and Ang-II Circulation 98 1998 794 799
7. D.A. Siwik, J.D. Tzortzis, D.R. Pimental, D.L.F. Chang, P.J. Pagano, K. Singh, D.B. Sawyer, and W.S. Colucci Inhibition of copper-zinc superoxide dismutase induces cell growth, hypertrophic phenotype, and apoptosis in neonatal rat cardiac myocytes in vitro Circ. Res. 85 1999 147 153
8. R.G. Allen, and M. Tresini Oxidative stress and gene regulation Free Radic. Biol. Med. 28 2000 463 499
9. R. Harrison Structure and function of xanthine oxidoreductase: where and now? Free Radic. Biol. Med. 33 2002 774 797
10. P.J. Pagano, J.K. Clark, M.E. Cifuentes-Pagano, S.M. Clark, G.M. Callis, and M.T. Quinn Localization of a constitutively active, phagocyte-like NADPH oxidase in rabbit aortic adventitia: enhancement by angiotensin II Proc. Natl. Acad. Sci. USA 94 1997 14483 14488
11. G.D. Frank, S. Eguchi, T. Yamakawa, S. Tanaka, T. Inagami, and E.D. Motley Involvement of reactive oxygen species in the activation of tyrosine kinase and extracellular signal-regulated kinase by Ang-II Endocrinology 141 2000 3120 3126
12. K.K. Griendling, D. Sorescu, and M. Ushio-Fukai NAD(P)H oxidase: role in cardiovascular biology and disease Circ. Res. 86 2000 494 501
13. P.N. Seshiah, D.S. Weber, P. Rocic, L. Valppu, Y. Taniyama, and K.K. Griendling Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators Circ. Res. 91 2002 406 413
14. C.K. Sen, and L. Packer Antioxidant and redox regulation of gene transcription FASEB J. 10 1996 709 720
15. K.A. Webster, D.J. Discher, S. Kaiser, O. Hernandez, B. Sato, J. Zang, and N.H. Bishopric Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53 J. Clin. Invest. 104 1999 239 252
16. J.J. Haddad Antioxidant and prooxidant mechanisms in the regulation of redox(y)-sensitive transcription factors Cell. Signalling 14 2002 879 897
17. W.M. Toone, B.A. Morgan, and N. Jones Redox control of AP-1-like factors in yeast and beyond Oncogene 20 2001 2336 2346
18. A.R. Brasier, M. Jamaluddin, Y. Han, C. Patterson, and S. Rung Angiotensin II induces gene transcription through cell-type-dependent effects on the nuclear factor-κB (NF-κB) transcription factor Mol. Cell. Biochem. 212 2000 155 169
19. G.N. Rao, K.A. Katki, N.R. Madamanchi, Y. Wu, and M.J. Birrer JunB forms the majority of the AP-1 complex and is a target for redox regulation by receptor tyrosine kinase and G protein-coupled receptor agonists in smooth muscle cells J. Biol. Chem. 274 1999 6003 6010
20. P. Paradis, W.R. MacLellan, N.S. Belaguli, R.J. Schwartz, and M.D. Schneider Serum response factor mediates AP-1-dependent induction of the skeletal alpha-actin promoter in ventricular myocytes J. Biol. Chem. 271 1996 10827 10833
21. P.L. Puri, M.L. Avantaggiati, V.L. Burgio, P. Chirillo, D. Collepardo, G. Natoli, C. Balsano, and M. Levrero Reactive oxygen intermediates mediate angiotensin II-induced c-Junc-Fos heterodimer DNA binding activity and proliferative hypertrophic responses in myogenic cells J. Biol. Chem. 270 1995 22129 22134
22. C. Viedt, U. Soto, H.I. Krieger-Brauer, J. Fei, C. Elsing, W. Kubler, and J. Kreuzer Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II: involvement of p22phox and reactive oxygen species Arterioscler. Thromb. Vasc. Biol. 20 2000 940 948
23. J.S. Yuichiro, H.J. Formanb, and A. Sevanianb Oxidants as stimulators of signal transduction Free Radic. Biol. Med. 22 1997 269 285
24. K.K. Griendling Novel NAD(P)H oxidases in the cardiovascular system Heart 90 2004 491 493
25. L. Van Heerebeek, C. Meischl, W. Stooker, C.J. Meijer, H.W. Niessen, and D. Roos NADPH oxidase(s): new source(s) of reactive oxygen species in the vascular system? J. Clin. Pathol. 55 2002 561 568
26. J. Sadoshima, L. Jahn, T. Takahashi, T.J. Kulik, and S. Izumo Molecular characterization of the stretch-induced adaptation of cultured cardiac cells: an in vitro model of load-induced cardiac hypertrophy J. Biol. Chem. 267 1992 10551 10560
27. R.P. Franke, S. Hopken, H. Schnittler, U. Dauer, R. Zangs, H. Kiesewetter, and C. Mittermayer Endothelial function and arteriosclerosis Onkologie 10 1987 250 252
28. R. Von Harsdorf, J.G. Edwards, Y. Shen, R.K. Kudej, R. Dietz, L.A. Leinwand, B. Nadal-Ginard, and S.F. Vatner Identification of a cis-acting regulatory element conferring inducibility of the atrial natriuretic factor gene in acute pressure overload J. Clin. Invest. 100 1997 1294 1304
29. G. Rothe, and G. Valet Flow cytometric assays of oxidative burst activity in phagocytes Methods Enzymol. 233 1994 539 548
30. J.M. Li, and A.M. Shah Intracellular localization and preassembly of the NADPH oxidase complex in cultured endothelial cells J. Biol. Chem. 277 2002 19952 19960
31. H. Aoki, M. Richmond, S. Izumo, and J. Sadoshima Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro Biochem. J. 347 2000 275 284
32. 2-terminal kinase in ventricular muscle cells J. Biol. Chem. 273 1998 5423 5426
33. S. Kim, and H. Iwao Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases Pharmacol. Rev. 52 2000 11 34
34. M. Shibanuma, T. Kuroki, and K. Nose Superoxide as a signal for increase in intracellular pH J. Cell. Physiol. 136 1988 379 383
35. J. Thorburn, M. McMahon, and A. Thorburn Raf-1 kinase activity is necessary and sufficient for gene expression changes but not sufficient for cellular morphology changes associated with cardiac myocyte hypertrophy J. Biol. Chem. 269 1994 30580 30586
36. S. Kim, Y. Izumi, M. Yano, A. Hamaguchi, K. Miura, S. Yamanaka, H. Miyazaki, and H. Iwao Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery Circulation 97 1998 1731 1737
37. 2-terminal kinase in cultured cardiac myocytes of neonatal rats Circ. Res. 80 1997 139 146
38. B. Derijard, M. Hibi, I.H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R.J. Davis JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain Cell 76 1994 1025 1037
39. R. Aikawa, I. Komuro, T. Yamazaki, Y. Zou, S. Kudoh, M. Tanaka, I. Shiojima, Y. Hiroi, and Y. Yazaki Oxidative stress activates extracellular signal-regulated kinases through Src and Ras in cultured cardiac myocytes of neonatal rats J. Clin. Invest. 100 1997 1813 1821
40. Y. Izumi, S. Kim, Y. Zhan, M. Namba, H. Yasumoto, and H. Iwao Important role of angiotensin II-mediated c-Jun NH(2)-terminal kinase activation in cardiac hypertrophy in hypertensive rats Hypertension 36 2000 511 516
41. C. Abate, L. Patel, F.J. Rauscher, and T. Curran Redox regulation of fos and jun DNA-binding activity in vitro Science 249 1990 1157 1161
42. S. Xanthoudakis, G. Miao, F. Wang, Y.C. Pan, and T. Curran Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme EMBO J. 11 1992 3323 3335
43. T.P. Dalton, H.G. Shertzer, and A. Puga Regulation of gene expression by reactive oxygen Annu. Rev. Pharmacol. Toxicol. 39 1999 67 101
44. T.M. Wallach, and A.W. Segal Analysis of glycosylation sites on gp91phox, the lavocytochrome of the NADPH oxidase, by site-directed mutagenesis and translation in vitro Biochem. J. 321 1997 583 585
45. C.D. Porter, F. Kuribayashi, M.H. Parkar, D. Roos, and C. Kinnon Detection of gp91-phox precursor protein in B-cell lines from patients with X-linked chronic granulomatous disease as an indicator for mutations impairing cytochrome b558 biosynthesis Biochem. J. 315 1996 571 575
46. A. Yamauchi, L. Yu, A.J. Potgens, F. Kuribayashi, H. Nunoi, S. Kanegasaki, D. Roos, H.L. Malech, M.C. Dinauer, and M. Nakamura Location of the epitope for 7D5, a monoclonal antibody raised against human flavocytochrome b558, to the extracellular peptide portion of primate gp91phox Microbiol. Immunol. 45 2001 249 257
47. U. Bayraktutan, L. Blayney, and A.M. Shah Molecular characterization and localization of the NAD(P)H oxidase components gp91-phox and p22-phox in endothelial cells Arterioscler. Thromb. Vasc. Biol. 20 2000 1903 1911
48. P.J. Pagano, S.J. Chanock, D.A. Siwik, W.S. Colucci, and J.K. Clark Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts Hypertension 32 1998 331 337
49. K.K. Griendling, C.A. Minieri, J.D. Ollerenshaw, and R.W. Alexander Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells Circ. Res. 74 1994 1141 1148
50. P.N. Seshiah, D.S. Weber, P. Rocic, L. Valppu, Y. Taniyama, and K.K. Griendling Angiotensin II stimulation of NAD(P)H oxidase activity: upstream mediators Circ. Res. 91 2002 406 413